NCT02082327View on ClinicalTrials.gov

A Phase 1 Study To Evaluate the Safety of Migalastat Hydrochloride Given Intravenously to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Fabry Disease
Interventions
DRUG

IV migalastat HCl

DRUG

IV placebo

DRUG

oral migalastat HCl

Trial Locations (1)

9713 GZ

PRA International, Groningen

Sponsors
All Listed Sponsors
lead

Amicus Therapeutics

INDUSTRY